… Therapy of systemic autoimmune rheumatic diseases can still be a challenge for
clinicians despite enormous progress made in the last decades on the understanding of the …

… treatment, follow up or patients characteristic. In this review, we have searched literature
concerning ECP use in rheumatic diseases. … use of therapeutic apheresis in rheumatic diseases …

… of such patients’ progress to ESRD without therapy with high dose immunosuppression …
used as an adjunct to conventional immunosuppressive therapy in patients with severe disease. …

… modalities aremycophenolate mofetil, chlorambucil, dexamethasone-cyclophosphamide,
IVIG therapy, TPE, ECPand rituximab [2]. The rationale for using TPE in the treatment of PV …

… of apheresis medicine and other physicians who may need to utilize therapeutic apheresis
(TA) … author reviewed any new developments in the understanding, current management, and …

… In this paper we report therapeutic apheresis procedures including emergency … The use of
apheresis remains stable in rheumatology, a medical specialty in which therapeutic progress …

… , since more than 45 years, has led in combination with immunosuppressive therapies and/…
Therapeutic apheresis is accepted as supportive therapy in all severe renal diseases such as …

… (s) of the disease and the post-apheresis rebound of newly synthesized CGs. Its use has
been … Therapeutic apheresis is an emergency treatment for CV patients with hyperviscosity …

… more advanced in Japan, and new therapeutic devices are being developed daily. New
treatment … New therapies using adsorption technology include a column for removing blood cells …

… exchange, double filtration plasmapheresis, rheopheresis, … application of TP for various
diseases ranging in different medical specialties, following the American Society for Apheresis (…